Pure Global AI
CDSCO UID MFG/MD/2020/000017_f105258cde4cbccb7d26083b8617c429_7a39eaca108f402a608c0d506e023b4b

LYPHOZYME UREA KIT(LYPHOZYME UREA )

Beacon Diagnostics Pvt. Ltd.Device Class Class BIndia CDSCOBrand: SEROCON CYSTATIN C CONTROL SET
VerifiedCDSCO · official registry
Registration details
UID
MFG/MD/2020/000017_f105258cde4cbccb7d26083b8617c429_7a39eaca108f402a608c0d506e023b4b
Device class
Class B
Brand name
SEROCON CYSTATIN C CONTROL SET
Approving authority
Gujarat
Product information
For the quantitative determination of Urea in serum,plasma and urine
About this record

LYPHOZYME UREA KIT(LYPHOZYME UREA ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000017_f105258cde4cbccb7d26083b8617c429_7a39eaca108f402a608c0d506e023b4b. This device is marketed under the brand name SEROCON CYSTATIN C CONTROL SET. The license holder is Beacon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.